Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Goodwin

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
International Journal of Cell Cloning|January 1, 1990
Lymphopoiesis and IL-7M B Widmer, P J Morrissey, R G Goodwin, et al.
Cell|May 7, 1993
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factorR G Goodwin, M R Alderson, C A Smith, et al.
Science (New York, N.Y.)|April 29, 1994
A lymphotoxin-beta-specific receptorP D Crowe, T L VanArsdale, B N Walter, et al.
Virology|November 5, 1997
Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptorsC A Smith, T D Smith, P J Smolak, et al.
European Journal of Immunology|October 1, 1993
Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorR G Goodwin, W S Din, T Davis-Smith, et al.
The American Journal of Pathology|August 1, 1996
CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissuesH J Gruss, A Pinto, A Gloghini, et al.
The EMBO Journal|October 6, 1997
TRAIL-R2: a novel apoptosis-mediating receptor for TRAILH Walczak, M A Degli-Esposti, R S Johnson, et al.
European Journal of Immunology|November 11, 1999
Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48M Z Kubin, D L Parshley, W Din, et al.
Nature Medicine|February 4, 1999
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivoH Walczak, R E Miller, K Ariail, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
International Journal of Cell Cloning|January 1, 1990
Lymphopoiesis and IL-7M B Widmer, P J Morrissey, R G Goodwin, et al.
Cell|May 7, 1993
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factorR G Goodwin, M R Alderson, C A Smith, et al.
Science (New York, N.Y.)|April 29, 1994
A lymphotoxin-beta-specific receptorP D Crowe, T L VanArsdale, B N Walter, et al.
Virology|November 5, 1997
Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptorsC A Smith, T D Smith, P J Smolak, et al.
European Journal of Immunology|October 1, 1993
Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factorR G Goodwin, W S Din, T Davis-Smith, et al.
The American Journal of Pathology|August 1, 1996
CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissuesH J Gruss, A Pinto, A Gloghini, et al.
The EMBO Journal|October 6, 1997
TRAIL-R2: a novel apoptosis-mediating receptor for TRAILH Walczak, M A Degli-Esposti, R S Johnson, et al.
European Journal of Immunology|November 11, 1999
Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48M Z Kubin, D L Parshley, W Din, et al.
Nature Medicine|February 4, 1999
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivoH Walczak, R E Miller, K Ariail, et al.
Pageof 6